Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats.
about
Bench-to-bedside review: Apoptosis/programmed cell death triggered by traumatic brain injury.Insights into the metabolic response to traumatic brain injury as revealed by (13)C NMR spectroscopyThe effect of PARP inhibitor on ischaemic cell death, its related inflammation and survival signals.Dietary curcumin supplementation counteracts reduction in levels of molecules involved in energy homeostasis after brain traumaCell death mechanisms and modulation in traumatic brain injury.Metabolic and histologic effects of sodium pyruvate treatment in the rat after cortical contusion injuryA novel PARP inhibitor L-2286 in a rat model of impact acceleration head injury: an immunohistochemical and behavioral study.Uric acid protects against secondary damage after spinal cord injury.Neuroprotection for traumatic brain injury: translational challenges and emerging therapeutic strategiesA review and rationale for the use of genetically engineered animals in the study of traumatic brain injury.Inhibition of poly(ADP-ribose) polymerase activity is insufficient to induce tetraploidy.Permeability transition pore-dependent and PARP-mediated depletion of neuronal pyridine nucleotides during anoxia and glucose deprivation.Metabolic Response of Pediatric Traumatic Brain Injury.A Combination Therapy of Nicotinamide and Progesterone Improves Functional Recovery following Traumatic Brain Injury.Microglial activation induced by brain trauma is suppressed by post-injury treatment with a PARP inhibitor.Poly(ADP-ribose) polymerase and the therapeutic effects of its inhibitors.Therapeutic applications of PARP inhibitors: anticancer therapy and beyondQuantification of poly(ADP-ribose)-modified proteins in cerebrospinal fluid from infants and children after traumatic brain injury.The pathophysiology of traumatic brain injury at a glance.Synaptic activity and bioenergy homeostasis: implications in brain trauma and neurodegenerative diseases.Drug targets for traumatic brain injury from poly(ADP-ribose)polymerase pathway modulation.PARP-1 inhibition attenuates neuronal loss, microglia activation and neurological deficits after traumatic brain injury.Parthanatos: mitochondrial-linked mechanisms and therapeutic opportunities.Identification of disease-related miRNAs based on co-expression network in spinal cord injury.Spatial and functional relationship between poly(ADP-ribose) polymerase-1 and poly(ADP-ribose) glycohydrolase in the brain.Association of poly(ADP-ribose) polymerase-1 polymorphism with Tourette syndrome.Prevention of traumatic brain injury-induced neuron death by intranasal delivery of nicotinamide adenine dinucleotide.Transforming growth factor-beta1 regulates the fate of cultured spinal cord-derived neural progenitor cells.Cell Death Mechanisms of Neurodegeneration.Cytoplasmic extracts from adipose tissue stromal cells alleviates secondary damage by modulating apoptosis and promotes functional recovery following spinal cord injury.MicroRNA 486 is a potentially novel target for the treatment of spinal cord injury.Docking study and binding free energy calculation of poly (ADP-ribose) polymerase inhibitors.
P2860
Q24802137-D088FE4A-1CDE-44A7-BD17-138C88536040Q26991838-3CA09AC5-990D-4438-8533-BDADAEF6E75CQ30957122-BEAD8DB6-B656-4999-A395-FADACEB5ADC5Q33587322-FBE3DE85-C7E3-4478-8DA0-4F88EB92EE2CQ33740409-1CBEB958-F1DA-40D4-ADD7-DB0C00FCB009Q33767257-F3E5EB5A-8340-440F-82DF-C0633834450BQ33853839-E5CEF2A0-77F1-4F10-91DA-B9AA5B3A6B93Q33927539-85CD59EA-2441-49A2-A51E-CE1F458D1FCFQ34147023-98B2DD64-2B35-4827-AFAF-515E927F7EA6Q34433733-EDA40F2D-2F91-4A1D-802F-721A00AE3281Q34570024-CB9AC329-A8DE-4AEE-8B24-0E356F6A0025Q35111721-622DE2B0-F775-4D4D-9103-C8B503026D71Q35513130-FC2A3E57-9778-4AB7-86CD-FE04FDF8E1B3Q35667075-20A56D90-BF35-458B-92BE-206461079F67Q35819584-A7FD119E-D872-4ABF-B1EE-2D1ABC6585CDQ36111918-BD2BCB13-2AED-4876-9BE3-840F0EEC7186Q36853236-3AEEA7C2-FBCE-46C0-8913-1877824E61ADQ36921177-581F5B39-EBD3-4E6B-8530-21B0BA3BFF89Q37287397-06175012-36CA-461B-BCAC-AB1DE150F461Q37382205-E4890381-9278-4621-A6BB-AFD3C39D52A3Q37445944-CB616786-38A5-44F8-9C2D-71358685261CQ37667705-811E8A89-7AD0-4862-B4B8-7C7DC2C601B9Q38200674-BE1F82CB-38D9-47A5-AE5F-68F24A20AAFAQ39173283-093CAA8A-A78C-42D9-A1C9-A036EA68FD5AQ40104867-F7ABEE03-3F9C-44D2-B75A-3E52AB95D533Q46034236-69FF9A49-6C5D-473E-86E0-1EF320D89F77Q46446197-943870ED-E657-4ED4-98C8-909FD8B390D2Q46705828-D22251BF-E78A-4446-8CAC-BCF1A52B1E75Q47961296-81289FFD-5BDA-46A7-B09B-48BA2C9819CEQ48185213-E92CD8AE-7B80-44E5-97E7-8458FFB02DA3Q48588381-4A705F48-61B7-4CD1-906D-E86AA0BC8841Q51612612-D63B0E96-FBED-463E-AE61-14DE8F192A4D
P2860
Pharmacologic inhibition of poly(ADP-ribose) polymerase is neuroprotective following traumatic brain injury in rats.
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Pharmacologic inhibition of poly
@nl
Pharmacologic inhibition of po ...... raumatic brain injury in rats.
@en
type
label
Pharmacologic inhibition of poly
@nl
Pharmacologic inhibition of po ...... raumatic brain injury in rats.
@en
prefLabel
Pharmacologic inhibition of poly
@nl
Pharmacologic inhibition of po ...... raumatic brain injury in rats.
@en
P2093
P1476
Pharmacologic inhibition of po ...... raumatic brain injury in rats.
@en
P2093
Bareyre FM
LaPlaca MC
McIntosh TK
Raghupathi R
P304
P356
10.1089/089771501750170912
P577
2001-04-01T00:00:00Z